Avanza Fonder’s Veracyte VCYT Stock Holding History

Avanza Fonder’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,101	Closed	-$997K	–	489
2025 Q1	$997K	Sell	33,101 -1,717	-5%	-$65.4K	0.03%	344
2024 Q4	$1.38M	Buy	+34,818	New	+$1.32M	0.04%	312

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avanza Fonder's VCYT Position: Q2 2025 in Review

Avanza Fonder sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 33,101 shares — an estimated $997K sold.

Avanza Fonder first reported a position in VCYT in Q4 2024 and held it in 2 quarters. The position peaked at $1.38M in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

Avanza Fonder reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
Avanza Fonder sold 33,101 Veracyte shares in Q2 2025, an estimated $997K.
Avanza Fonder first reported a position in Veracyte in Q4 2024 and held it in 2 quarters.
Avanza Fonder's Veracyte position peaked at $1.38M in Q4 2024.
278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Avanza Fonder's 13F filing for Q2 2025, filed 14 Jul 2025.